Nolatrexed Dihydrochloride

盐酸诺拉曲塞

Report date: 2024/05/19 20:00:11
NME

Base Information

Drug NameNolatrexed Dihydrochloride
Drug Alias Name迪奥Nolatrexedum洛拉曲克盐酸洛拉曲克盐酸诺拉曲特 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsNasopharyngeal NeoplasmsLiver NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[4] 
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaDiscontinued
Originator CompaniesPfizer Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesEximias PharmaceuticalBeijing Konruns Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNasopharyngeal NeoplasmsLiver NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4] 

Other Information

ATC CodeN/A
Related LinksN/A